Cargando…

Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma

In 2012, it was estimated that 9180 people in the United States would die from melanoma and that more than 76,000 new cases would be diagnosed. Surgical resection is effective for early-stage melanoma, but outcomes are poor for patients with advanced disease. Expression of tumor-associated antigens...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufman, Howard L, Ruby, Carl E, Hughes, Tasha, Slingluff, Craig L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072479/
https://www.ncbi.nlm.nih.gov/pubmed/24971166
http://dx.doi.org/10.1186/2051-1426-2-11